HPMC improves protective effects of naringenin and isonicotinamide co-crystals against abdominal aortic aneurysm
- 7 September 2021
- journal article
- research article
- Published by Springer Nature in Cardiovascular Drugs and Therapy
- Vol. 36 (6) , 1109-1119
Abstract
Purpose Abdominal aortic aneurysm (AAA) rupture is one of the most common causes of mortality in cardiovascular diseases, but currently there is no approved drug for AAA treatment or prevention in the clinic. Naringenin (NGN) has been reported to have anti-AAA effects. However, water solubility and in vivo absorption of NGN are not satisfactory, which leads to its low bioavailability, thus affecting its pharmacological effects. In this project, the improving effects of isonicotinamide (INT) co-crystal and hydroxy propyl methyl cellulose (HPMC) or polyvinyl pyrrolidone (PVP) on the solubility, in vivo absorption, and anti-AAA effects of NGN were evaluated. Methods In the current study, co-crystals of naringenin-isonicotinamide (NGN-INT) were prepared, and effects of PVP or HPMC on precipitation rate, supersaturation, and bioavailability of NGN were explored. In addition, with or without HPMC supply, the effects of NGN-INT co-crystal on anti-AAA efficacy of NGN were investigated on an elastase-induced AAA mouse model, and the results were compared with the efficacy of the NGN crude drug. Results Our results demonstrate that NGN-INT formulation, compared to the NGN crude drug, enhanced the dissolution rate of NGN and significantly increased Cmax and AUC(0–∞) of NGN by 18 times and 1.97 times, respectively. Addition of PVP or HPMC in NGN-INT co-crystal further increased bioavailability of NGN in NGN-INT. The in vivo pharmacodynamic study showed that NGN-INT with HPMC significantly improved the inhibitory effects of NGN against AAA. Conclusion NGN-INT significantly improved the absorption and aortic protective effects of NGN. The supersaturation-prolonging effect of HPMC further enhanced bioavailability and anti-AAA effects of NGN-INT. Graphical abstractKeywords
Funding Information
- National Natural Science Foundation of China (No. U1803125)
- National key research and development program (No. 2019YFE0113500)
This publication has 24 references indexed in Scilit:
- Solubility Advantage of Amorphous Drugs and Pharmaceutical CocrystalsCrystal Growth & Design, 2011
- FINDING SOLUTIONS2010
- Supersaturating Drug Delivery Systems: The Answer to Solubility-Limited Oral Bioavailability?Journal of Pharmaceutical Sciences, 2009
- Combined Use of Crystalline Salt Forms and Precipitation Inhibitors to Improve Oral Absorption of Celecoxib from Solid Oral FormulationsJournal of Pharmaceutical Sciences, 2007
- Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugsExpert Opinion on Drug Delivery, 2005
- Persistent increase in the incidence of abdominal aortic aneurysm in Scotland, 1981–2000British Journal of Surgery, 2003
- Risk Factors for Abdominal Aortic Aneurysms in Older Adults Enrolled in the Cardiovascular Health StudyArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Epidemiology of aortic aneurysm in the United StatesJournal of Clinical Epidemiology, 1995
- Conteol of Crystal Growth in Drug Suspensions: 1) Design of a Conteol Unit and Application to Acetaminophen Suspensions)Drug Development and Industrial Pharmacy, 1988
- Lack of Carcinogenicity of Nicotinamide and Isonicotinamide following Lifelong Administration to MiceOncology, 1983